Issue 2/2019
Content (9 Articles)
Bispecific Antibodies in Hematologic Malignancies: When, to Whom, and How Should Be Best Used?
Roberta Demichelis-Gómez, Daniela Pérez-Sámano, Christianne Bourlon
New Treatment Options for Acute Myeloid Leukemia in 2019
Marco Cerrano, Raphael Itzykson
Communicating with Adolescents and Young Adults about Cancer-Associated Weight Loss
Joanne Reid, Clare McKeaveney, Peter Martin
Novel Approaches for Treating Pain in Children
William Splinter
Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid
Harsh K. Patel, Alok A. Khorana
Pegylated Interleukin-10: Clinical Development of an Immunoregulatory Cytokine for Use in Cancer Therapeutics
Karen Autio, Martin Oft
TRK Inhibitors: Clinical Development of Larotrectinib
Munveer S. Bhangoo, Darren Sigal
BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
Sofia Genta, Maria Cristina Pirosa, Anastasios Stathis
Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
Jerry Harb, Pen-Jen Lin, Jijun Hao